A pediatric animal model to evaluate the effects of disuse on musculoskeletal growth and development.
/in Publications/by awp-adminProlonged Pharmacokinetic and Pharmacodynamic Actions of a Pegylated Parathyroid Hormone (1-34) Peptide Fragment.
/in Publications/by awp-adminRegulation of Sclerostin Expression in Multiple Myeloma by Dkk-1: A Potential Therapeutic Strategy for Myeloma Bone Disease.
/in Publications/by awp-adminCortical and trabecular deterioration in mouse models of Roux-en-Y gastric bypass.
/in Publications/by awp-admin1,25-Dihydroxyvitamin D Alone Improves Skeletal Growth, Microarchitecture and Strength in a Murine Model of XLH, Despite Enhanced FGF23 Expression.
/in Publications/by awp-adminPD-L1 Is Upregulated by Simultaneous Amplification of the PD-L1 and JAK2 Genes in Non-Small Cell Lung Cancer.
/in Publications/by awp-adminIkeda S, Okamoto T, Okano S, Umemoto Y, Tagawa T, Morodomi Y, Kohno M, Shimamatsu S, Kitahara H, Suzuki Y, Fujishita T, Maehara Y
PD-L1 Is Upregulated by Simultaneous Amplification of the PD-L1 and JAK2 Genes in Non-Small Cell Lung Cancer.
J Thorac Oncol. 2016;11(1):62-71 – PMID: 26762740
Bone Turnover Markers in the Diagnosis and Monitoring of Metabolic Bone Disease.
/in Publications/by awp-adminGreenblatt MB, Tsai JN, Wein MN
Bone Turnover Markers in the Diagnosis and Monitoring of Metabolic Bone Disease.
Clin Chem. 2016;63(2):464-474
Relationship between bone turnover and density with teriparatide, denosumab or both in women in the DATA study.
/in Publications/by awp-adminTsai JN, Burnett-Bowie SM, Lee H, Leder BZ
Relationship between bone turnover and density with teriparatide, denosumab or both in women in the DATA study.
Bone. 2016;95:20-25
Loss of Gsα in the Postnatal Skeleton Leads to Low Bone Mass and a Blunted Response to Anabolic Parathyroid Hormone Therapy.
/in Publications/by awp-adminSinha P, Aarnisalo P, Chubb R, Poulton IJ, Guo J, Nachtrab G, Kimura T, Swami S, Saeed H, Chen M, Weinstein LS, Schipani E, Sims NA, Kronenberg HM, Wu JY
Loss of Gsα in the Postnatal Skeleton Leads to Low Bone Mass and a Blunted Response to Anabolic Parathyroid Hormone Therapy.
J Biol Chem. 2015;291(4):1631-42 – PMID: 26598522 – PMCID: PMC4722446